Title:
BROMODOMAIN INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2018/068283
Kind Code:
A1
Abstract:
Provided herein are compounds of formula (I) wherein R 1, Y, L 1, G 1, X 1, X 2, L 2, R 2, R 3, and R 4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, which are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).
Inventors:
COWART MARLON (US)
FIDANZE STEVEN (US)
HASVOLD LISA (US)
LIU DACHUN (US)
MCDANIEL KEITH (US)
PRATT JOHN (US)
SHEPPARD GEORGE (US)
WANG LE (US)
FIDANZE STEVEN (US)
HASVOLD LISA (US)
LIU DACHUN (US)
MCDANIEL KEITH (US)
PRATT JOHN (US)
SHEPPARD GEORGE (US)
WANG LE (US)
Application Number:
PCT/CN2016/102074
Publication Date:
April 19, 2018
Filing Date:
October 14, 2016
Export Citation:
Assignee:
ABBVIE INC (US)
ABBVIE PHARMACEUTICAL TRADING SHANGHAI CO LTD (CN)
ABBVIE PHARMACEUTICAL TRADING SHANGHAI CO LTD (CN)
International Classes:
C07D403/12; A61K31/4412; A61P35/00; C07D401/12; C07D401/14; C07D405/12; C07D413/12; C07D417/12
Foreign References:
| CN104884451A | 2015-09-02 | |||
| CN104136435A | 2014-11-05 | |||
| CN105939996A | 2016-09-14 |
Other References:
See also references of EP 3526210A4
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF: